Life
Many cancer patients don’t get genomic tests to guide treatment, study finds
Strategic angle: Even as therapies improve, a startling number of cancer patients are not getting genomic tests that could improve their chance of survival.
Editorial Staff
1 min read
Updated 10 days ago
A study has found that a significant number of cancer patients are not undergoing genomic testing, which is critical for personalized treatment strategies.
Genomic tests can identify specific mutations and guide oncologists in selecting the most effective therapies, potentially improving survival rates.
The findings suggest a need for improved integration of genomic testing into standard cancer care protocols to enhance patient outcomes.